AU2001264900A1 - Pharmaceutical use of fibulin-1 - Google Patents
Pharmaceutical use of fibulin-1Info
- Publication number
- AU2001264900A1 AU2001264900A1 AU2001264900A AU6490001A AU2001264900A1 AU 2001264900 A1 AU2001264900 A1 AU 2001264900A1 AU 2001264900 A AU2001264900 A AU 2001264900A AU 6490001 A AU6490001 A AU 6490001A AU 2001264900 A1 AU2001264900 A1 AU 2001264900A1
- Authority
- AU
- Australia
- Prior art keywords
- fibulin
- pharmaceutical use
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102100031812 Fibulin-1 Human genes 0.000 title 1
- 101710170731 Fibulin-1 Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pregnancy & Childbirth (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57749900A | 2000-05-24 | 2000-05-24 | |
| US09/577,499 | 2000-05-24 | ||
| PCT/US2001/016791 WO2001089548A2 (en) | 2000-05-24 | 2001-05-24 | Pharmaceutical use of fibulin-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001264900A1 true AU2001264900A1 (en) | 2001-12-03 |
Family
ID=24308988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001264900A Abandoned AU2001264900A1 (en) | 2000-05-24 | 2001-05-24 | Pharmaceutical use of fibulin-1 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1301195A2 (en) |
| JP (1) | JP2004504275A (en) |
| AU (1) | AU2001264900A1 (en) |
| WO (1) | WO2001089548A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011500856A (en) * | 2007-10-31 | 2011-01-06 | シーアールシー フォー アズマ アンド エアウェイズ エルティーディー | Methods and compositions for modulating airway tissue remodeling |
| WO2010010201A1 (en) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Gene expression profile as a marker of endometrial receptivity |
| SMT202400270T1 (en) | 2014-06-17 | 2024-07-09 | Asherman Therapy S L | Stem cell therapy in endometrial pathologies |
| CN113621699A (en) * | 2021-08-10 | 2021-11-09 | 张存泰 | Fibulin-1 protein as vascular aging molecular marker and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6299390A (en) * | 1989-08-18 | 1991-04-03 | American National Red Cross, The | Fibulin |
| WO1997038014A1 (en) * | 1996-04-04 | 1997-10-16 | Amgen Inc. | Fibulin pharmaceutical compositions and related methods |
-
2001
- 2001-05-24 WO PCT/US2001/016791 patent/WO2001089548A2/en not_active Ceased
- 2001-05-24 AU AU2001264900A patent/AU2001264900A1/en not_active Abandoned
- 2001-05-24 JP JP2001585791A patent/JP2004504275A/en active Pending
- 2001-05-24 EP EP01939374A patent/EP1301195A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004504275A (en) | 2004-02-12 |
| WO2001089548A2 (en) | 2001-11-29 |
| WO2001089548A3 (en) | 2003-01-23 |
| EP1301195A2 (en) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001235691A1 (en) | Use of paullone derivatives for making medicines | |
| AU2001277741A1 (en) | 2-aminopyridine compounds and use thereof as drugs | |
| AU2002239370A1 (en) | Signal tampon | |
| AU2001280188A1 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
| AU2001269508A1 (en) | Drugs or cosmetics | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| AU2001275007A1 (en) | Methods of testing materials | |
| AU2002232468A1 (en) | Pharmaceutical heterocyclic compounds | |
| AU2002221099A1 (en) | Combination drugs | |
| AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
| AU2002230781A1 (en) | Pharmaceutical uses and synthesis of benzobicyclooctanes | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2001264900A1 (en) | Pharmaceutical use of fibulin-1 | |
| AU2001251004A1 (en) | Detection of viable agents | |
| AU2001268236A1 (en) | Use of aicar and related compounds | |
| AU4432001A (en) | Trityl-type compounds and their use | |
| AU2001292578A1 (en) | Pharmaceutical compounds | |
| AU3586401A (en) | Pharmaceutical composition | |
| AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
| AU2001272490A1 (en) | Use of galiella lactone | |
| AU2001278705A1 (en) | Pharmaceutical composition | |
| AU2001228784A1 (en) | Inositol derivatives and their pharmaceutical use | |
| AU2001259564A1 (en) | Pharmaceutical compositions and methods for use | |
| AU2001276556A1 (en) | Novel pharmaceutical use of quinnoline derivatives | |
| AU2002215923A1 (en) | Use of medicaments |